TSC Stocks Under $10
Editor's Note: This was originally published as an alert at 11:20 a.m. EST on Dec. 23 to subscribers of TheStreet.com's Stocks Under $10. The stock prices and returns have been updated to reflect today's levels.
Earlier this month we put together a basket of five low-priced stocks that we believed would outperform the market in December due to increased investor demand for speculative stocks. The moves we were seeing in stocks like Sirius (SIRI) and Genta (GNTA) seeded this concept. Here they are again, along with a performance table to track our performance: Stemcells (STEM) is up 22% at $3.62.Aphton (APHT) is off 2.5% at $3.14.
E-Loan (EELN) is up 15% at $3.31.
Tut Systems (TUTS) is up 2.4% at $3.84.
OpenTV (OPTV) is essentially flat at $3.82. Last night we had two double-digit gainers; Aphton and E-Loan, and today, we can add Stemcells to the list. News that stem cells could be used to treat often-fatal cystic fibrosis has the stock trading 15% higher to $3.58 a share. (Geron, our stem-cell play in the model portfolio, already has climbed 15% this week.) We would be locking in gains in some of the names today if we owned them for our model portfolio, and now we want to elaborate on why this portfolio worked. On the whole, the portfolio is 7% higher than the Dec. 8 entry prices, while the S&P 500 is up 2.97% during the same period. (Readers who took some gains off the table in Aphton on Dec. 10 and E-Loan on Dec. 10 and Dec. 15 have a 10.92% gain.) We would close out of Aphton here for a 10.91% gain. No phase III data have been reported yet for its gastrointestinal cancer vaccine, and we view the risk/reward here as more negative than it was earlier this month.
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn MoreOptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn MoreReal Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn MoreStocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,393.45 | 1,310.33 | 2,827.34 | 15.81 |
Oil *
101.80
|
|
DOWN
26.41 |
DOWN
2.99 |
DOWN
10.02 |
DOWN
0.44 |
10 Yr
1.58%
SPDR Gold
151.62
|
|
-0.21%
|
-0.23%
|
-0.35%
|
-2.71%
|
Data delayed 20 minutes |


Connect with TheStreet